RCM
AURA icon

Regency Capital Management’s Aura Biosciences AURA Stock Holding History

Regency Capital Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.56M Sell
532,495
-6,089
-1% -$34.9K 1.59% 21
2025
Q4 		$2.94M Sell
538,584
-74,105
-12% -$440K 1.22% 30
2025
Q3 		$3.79M Sell
612,689
-53,192
-8% -$348K 1.8% 22
2025
Q2 		$4.17M Sell
665,881
-83,601
-11% -$489K 2.19% 18
2025
Q1 		$4.39M Buy
749,482
+140,058
+23% +$1.06M 2.62% 14
2024
Q4 		$5.01M Sell
609,424
-57,887
-9% -$545K 2.71% 15
2024
Q3 		$5.95M Sell
667,311
-97,744
-13% -$838K 3.27% 13
2024
Q2 		$5.78M Sell
765,055
-20,081
-3% -$147K 3.72% 10
2024
Q1 		$6.16M Buy
785,136
+80,162
+11% +$665K 3.92% 10
2023
Q4 		$6.25M Buy
704,974
+177,996
+34% +$1.51M 4.2% 7
2023
Q3 		$4.73M Sell
526,978
-5,355
-1% -$57.6K 4.02% 9
2023
Q2 		$6.57M Sell
532,333
-11,342
-2% -$121K 5.72% 6
2023
Q1 		$5.05M Sell
543,675
-10,611
-2% -$110K 6.11% 5
2022
Q4 		$5.82M Buy
554,286
+329,732
+147% +$4.2M 6.69% 5
2022
Q3 		$4.07M Sell
224,554
-30,068
-12% -$455K 4.99% 6
2022
Q2 		$3.61M Buy
+254,622
New +$4.21M 3.88% 12

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Regency Capital Management's AURA Position: Q1 2026 in Review

Regency Capital Management reduced its Aura Biosciences (AURA) stake by 1.1% in Q1 2026, selling an estimated $34.9K and leaving 532,495 shares worth $3.56M. The position accounts for 1.59% of the portfolio, ranked #21.

Regency Capital Management first reported a position in AURA in Q2 2022 and has held it in 16 quarters since. The position peaked at $6.57M in Q2 2023. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Regency Capital Management held 532,495 shares of Aura Biosciences worth $3.56M as of Q1 2026.
  • Regency Capital Management sold 6,089 Aura Biosciences shares in Q1 2026, an estimated $34.9K.
  • Aura Biosciences made up 1.59% of Regency Capital Management's portfolio in Q1 2026, its #21 holding.
  • Regency Capital Management first reported a position in Aura Biosciences in Q2 2022 and has held it in 16 quarters since.
  • Regency Capital Management's Aura Biosciences position peaked at $6.57M in Q2 2023.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Regency Capital Management's 13F filing for Q1 2026, filed 5 May 2026.